Eagle Claw Capital Managment, LLC Abbott Laboratories Transaction History
Eagle Claw Capital Managment, LLC
- $538 Million
- Q1 2024
A detailed history of Eagle Claw Capital Managment, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Eagle Claw Capital Managment, LLC holds 2,885 shares of ABT stock, worth $300,097. This represents 0.06% of its overall portfolio holdings.
Number of Shares
2,885
Previous 2,685
7.45%
Holding current value
$300,097
Previous $295,000
10.85%
% of portfolio
0.06%
Previous 0.06%
Shares
16 transactions
Others Institutions Holding ABT
# of Institutions
3,130Shares Held
1.29BCall Options Held
8.43MPut Options Held
8.71M-
Vanguard Group Inc Valley Forge, PA165MShares$17.2 Billion0.38% of portfolio
-
Black Rock Inc. New York, NY133MShares$13.8 Billion0.36% of portfolio
-
Capital Research Global Investors Los Angeles, CA84MShares$8.74 Billion2.23% of portfolio
-
State Street Corp Boston, MA74.7MShares$7.77 Billion0.39% of portfolio
-
Capital International Investors Los Angeles, CA70.2MShares$7.3 Billion1.65% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $182B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...